China trial shows gum tissue stem cells help 55% of lifetime diabetes patients
新聞摘要
以下為來源提供的節錄，完整報道請查看原文。
A randomised phase 1 clinical trial conducted by scientists and doctors from Shanghai and Guangzhou has achieved encouraging results in the treatment of Type 1 diabetes using stem cells extracted from the mouth’s gum tissue. More than half of those who received the treatment showed varying degrees of improvement, while one subject was able to discontinue exogenous insulin therapy completely, the researchers said.